Varian to buy Boston Scientific’s portfolio of drug-loadable microsphere and bland embolic bead products

Varian has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumours. The planned acquisition of the drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products, a press release reports, will enable Varian to extend its new [...]

2019-07-08T16:13:34+00:00July 8th, 2019|Tags: , , |

Celling Spine acquires Link Spine with goal of further developing a cell-centric spinal platform

Celling Spine—a subsidiary of Celling Biosciences—has acquired all the assets of Link Spine, which is a subsidiary of Link Orthopedics. A press release reports that Link Orthopedics is a global leader in orthopaedic technologies and was looking for a company to further develop a comprehensive spinal fusion system focused on facet fixation and minimally [...]

2019-07-08T15:53:25+00:00July 8th, 2019|Tags: , , |
Go to Top